Surging PHEV sales at cost of FY23E net profit
The Hidden Toll of Drug Price Controls: Fewer New Treatments and Higher Medical Costs for the World
NIO’s cost control disappoints us again
3Q miss; new models, cost cut as key in FY25
China Consumer Staples – Easing raw material pressure underpins cost savings
FY2023—Output Cost Estimates and Budget Outturn
A New Architecture to Manage Data Costs and Complexity
China Food & Beverage Sector - FY23 growth from re-opening and falling costs
Quantifying Potential Cost Avoidance Implications of Outcomes Reported in Behavioral and Social Science Research
Monthly Outlook 202309: US Corporate Earnings Set to Rebound? Hiring Cost Is the Biggest Risk
公众号
小程序
社群
公众号小程序社群